The technology used in the InBody BPBIO250, to measure blood pressure, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★★ Recommendation||Recent clinical validation; recent protocol|
|BIHS (UK and IRL)||Professional use||Published evidence|
|Stride BP||Office use for adults (Preferred)||Published evidence|
Kollias A, Gravvani A, Anagnostopoulos I, Kyriakoulis KG, Bountzona I, Menti A, Stergiou GS. Validation of the InBody BPBIO250 oscillometric blood pressure monitor for professional office use in general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard Blood Press Monit. 2020 Apr;25(2):115-117. Epub: 2020 Jan 4. doi: 10.1097/MBP.0000000000000428. PMID: 31913149.
81060-2:2019 - Pass General population (Note: Medium (22 cm to 32 cm) and Large (32 cm to 42 cm) cuffs tested)